AEYE Health Wins 2026 Prix Galien Award for AI Eye Screening
New York, USA, November 3, 2026 AEYE Health, a healthcare technology company specializing in autonomous artificial intelligence for medical...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
New York, USA, November 3, 2026 AEYE Health, a healthcare technology company specializing in autonomous artificial intelligence for medical...
Austin, Texas & New York, August 5, 2026 The Foundation for Angelman Syndrome Therapeutics (FAST) has announced a strategic...
New York, August 4, 2026 AEYE Health has announced the publication of a real-world clinical study in the British...
